MedPath

Oncorena AB

Oncorena AB logo
🇳🇴Norway
Ownership
Subsidiary
Established
2011-01-01
Employees
11
Market Cap
-
Website
http://www.oncorena.com

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Phase 1
Recruiting
Conditions
Carcinoma, Renal Cell
Interventions
First Posted Date
2022-03-18
Last Posted Date
2024-06-24
Lead Sponsor
Oncorena AB
Target Recruit Count
50
Registration Number
NCT05287945
Locations
🇸🇪

Karolinska University Hospital, Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath